{"transactions":[{"id":2229638,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":126089,"kind":"person","name":"Makara Richard","position":1,"cik":"0001798130","reported_name":"Makara Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Head of Accting;Controller"}}],"security":"Common Stock","published_at":"2022-06-16T21:14:11.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs will vest on the earlier of (i) December 31, 2022, or (ii) the appointment of the Issuer's new Chief Financial Officer, subject to the Reporting Person's continued service to the Issuer as of such vesting date."}],"balance_after":13583,"source":{"system":"sec-edgar","filing":"0001209191-22-037523","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919122037523/doc4.xml","form_type":"4"}},{"id":3245913,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":126089,"kind":"person","name":"Makara Richard","position":1,"cik":"0001798130","reported_name":"Makara Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Head of Accting;Controller"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-02-26T22:12:12.000Z","date":"2020-02-24","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares shall vest and become exercisable in a series of 48 successive equal monthly installments beginning on March 24, 2020, in each case subject to the Reporting Person's continued service (as that term is defined in the Issuer's 2014 Equity Incentive Plan) as of each such date."}],"balance_after":30000,"derivative":{"exercise_price":16.36,"expiration_date":"2030-02-24","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-20-013111","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919120013111/doc4.xml","form_type":"4"}}]}